Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

G2B among the 6 finalist startups at the Trans-Atlantic Angel Conference

Events, News

Next week, on Thursday, 5th December, the six finalist startups of the Trans-Atlantic Angel Conference (TAAC 6) will take the stage for their final pitch at the Demo Day.

These companies are redefining industries with their groundbreaking solutions, and today, we’re excited to spotlight one of them:

Meet Gate2Brain S.L. – TAAC#6 Finalist Transforming Medicine
👉 https://gate2brain.com/

Gate2Brain, a Catalan biotech startup born during the pandemic, is revolutionising how medicines reach the brain. With a patented peptide-based platform technology, they’re solving a critical problem: delivering drugs to the brain while bypassing the blood-brain barrier.

𝗪𝗵𝗮𝘁 𝗧𝗵𝗲𝘆 𝗗𝗼:

Gate2Brain uses peptides as “shuttles” to transport therapies directly to the brain. This approach enables treatments for conditions like pediatric brain tumors to become more effective and less harmful, reducing side effects.

Gat2Brain 𝗠𝗶𝘀𝘀𝗶𝗼𝗻:

➡️ Address brain diseases where a potential therapy needs a better transport. Starting with pediatric brain tumors, a devastating diagnosis with limited treatment options.

➡️ Partner with institutions like Sant Joan de Déu Hospital to bring life-saving therapies to children. Later the technology could be used in many other diseases impacting millions of people worldwide.

𝗔 𝗦𝘁𝗮𝗿𝘁𝘂𝗽 𝗕𝗮𝗰𝗸𝗲𝗱 𝗯𝘆 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻:

➡️ Spin-off of University of Barcelona, IRB Barcelona, and Sant Joan de Déu Pediatric Hospital with a portfolio of 6 patents.

➡️ Secured €4.5M+ in national and international funding, including support from the EIC Accelerator and Botín Foundation.

➡️ Opening a new investment round to advance their preclinical phase and pave the way for clinical trials within two years.

Gate2Brain isn’t just creating technology; they’re offering hope. As CEO Meritxell Teixido explains: “𝘐𝘵’𝘴 𝘭𝘪𝘬𝘦 𝘴𝘩𝘶𝘵𝘵𝘭𝘦𝘴 𝘵𝘩𝘢𝘵 𝘤𝘢𝘳𝘳𝘺 𝘥𝘳𝘶𝘨𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘣𝘳𝘢𝘪𝘯, 𝘥𝘦𝘭𝘪𝘷𝘦𝘳𝘪𝘯𝘨 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵𝘴 𝘸𝘩𝘦𝘳𝘦 𝘵𝘩𝘦𝘺’𝘳𝘦 𝘯𝘦𝘦𝘥𝘦𝘥 𝘮𝘰𝘴𝘵.”

💬 What excites you most about Gate2Brain’s work? Share your thoughts below!

📅 See Gate2Brain pitch live at the TAAC 6 Demo Day on December 5th. [https://lnkd.in/eY3VkACd]

Published by Startup Investor Accelerator – Event

November 25, 2024/by noticias
Tags: finalist, pitch, startup investor, TACC
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2024/11/startup-investor.png 380 520 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2024-11-25 17:50:482024-11-25 17:50:48G2B among the 6 finalist startups at the Trans-Atlantic Angel Conference
You might also like
Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient careGate2Brain at MIT Pitch Day at University of Cambridge
Plug & Play Biotech Pitch
Winner of the Innovator’s Pitch Challenge Award at RESI Europe 2024

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10
  • Gate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric OncologyFebruary 20, 2025 - 10:19

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
RESI London 2024Gate2Brain and its “molecular tractors” technology: new way to optimize...
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}